Cargando…

Special Issues Encountered When Cancer Patients Confront COVID-19

Since the beginning of the COVID-19 global pandemic, there has been insufficient evidence and experience to help oncologists understand how to deal with infected and non-infected cancer patients. Many hospitals worldwide have shared their experiences of managing such patients by using the internet t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Lina, Wang, Kailai, Ye, Chenyang, Zheng, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426396/
https://www.ncbi.nlm.nih.gov/pubmed/32850443
http://dx.doi.org/10.3389/fonc.2020.01380
_version_ 1783570673575133184
author Qi, Lina
Wang, Kailai
Ye, Chenyang
Zheng, Shu
author_facet Qi, Lina
Wang, Kailai
Ye, Chenyang
Zheng, Shu
author_sort Qi, Lina
collection PubMed
description Since the beginning of the COVID-19 global pandemic, there has been insufficient evidence and experience to help oncologists understand how to deal with infected and non-infected cancer patients. Many hospitals worldwide have shared their experiences of managing such patients by using the internet to reach non-infected cancer patients. However, for infected or suspected infected cancer patients, their experiences in terms COVID-19 diagnosis, anticancer treatment and prognosis are largely unknown and controversial. Here, we summarize the incidence, severe illness rate and mortality according to the published clinical data of COVID-19 in cancer patients and discuss the diagnostic difficulties, anticancer treatment and prognosis of COVID-19-infected cancer patients.
format Online
Article
Text
id pubmed-7426396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74263962020-08-25 Special Issues Encountered When Cancer Patients Confront COVID-19 Qi, Lina Wang, Kailai Ye, Chenyang Zheng, Shu Front Oncol Oncology Since the beginning of the COVID-19 global pandemic, there has been insufficient evidence and experience to help oncologists understand how to deal with infected and non-infected cancer patients. Many hospitals worldwide have shared their experiences of managing such patients by using the internet to reach non-infected cancer patients. However, for infected or suspected infected cancer patients, their experiences in terms COVID-19 diagnosis, anticancer treatment and prognosis are largely unknown and controversial. Here, we summarize the incidence, severe illness rate and mortality according to the published clinical data of COVID-19 in cancer patients and discuss the diagnostic difficulties, anticancer treatment and prognosis of COVID-19-infected cancer patients. Frontiers Media S.A. 2020-08-07 /pmc/articles/PMC7426396/ /pubmed/32850443 http://dx.doi.org/10.3389/fonc.2020.01380 Text en Copyright © 2020 Qi, Wang, Ye and Zheng. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Qi, Lina
Wang, Kailai
Ye, Chenyang
Zheng, Shu
Special Issues Encountered When Cancer Patients Confront COVID-19
title Special Issues Encountered When Cancer Patients Confront COVID-19
title_full Special Issues Encountered When Cancer Patients Confront COVID-19
title_fullStr Special Issues Encountered When Cancer Patients Confront COVID-19
title_full_unstemmed Special Issues Encountered When Cancer Patients Confront COVID-19
title_short Special Issues Encountered When Cancer Patients Confront COVID-19
title_sort special issues encountered when cancer patients confront covid-19
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426396/
https://www.ncbi.nlm.nih.gov/pubmed/32850443
http://dx.doi.org/10.3389/fonc.2020.01380
work_keys_str_mv AT qilina specialissuesencounteredwhencancerpatientsconfrontcovid19
AT wangkailai specialissuesencounteredwhencancerpatientsconfrontcovid19
AT yechenyang specialissuesencounteredwhencancerpatientsconfrontcovid19
AT zhengshu specialissuesencounteredwhencancerpatientsconfrontcovid19